- Launches 'Feel Life' campaign in 18 countries across
Asia Pacific, Middle East, India, and Africa to raise awareness on Peripheral
Neuropathy
- Global Webinar Series for healthcare professionals with
'Virtual Pavilions' representing Peripheral neuropathy
issues in each country, along with best practices, case studies and
expert panels.
SINGAPORE, May 17, 2022 /PRNewswire/ -- P&G Health, the
health care division of Procter & Gamble (NYSE:PG) makers of
Neurobion, announced its new 'Feel Life campaign' commemorating
Neuropathy Awareness Week 2022 across 18 countries in Asia Pacific, Middle
East, and Africa. With a
host of digital and on-ground activities in collaboration with
physicians, pharmacists, medical and partner associations, the
campaign aims to raise public awareness on Peripheral Neuropathy
towards early identification and timely treatment.
Peripheral neuropathy (PN) is a chronic clinical
condition, wherein the peripheral nervous system is damaged.
Symptoms of peripheral neuropathy include numbness, tingling,
prickling, and burning sensations in the hands and feet. Sufferers
of PN report impacts on their quality of life including reduced
physical abilities and poor sleep. With Diabetes Mellitus being the
leading cause[1] of peripheral neuropathy, the
increasing prevalence of Peripheral Neuropathy is closely linked to
the rise in the number of diabetic patients. Besides diabetes
mellitus, B vitamins deficiencies and aging are other high-risk
factors leading to peripheral nerve damage.
"In 2021, there were 393 million diabetic
patients[2] in the Asia
Pacific, Middle East, and
African regions with projections of there being up to 603 million
diabetic patients in these regions by 2045[2]. With an
approximate 50%[2] of diabetic patients indicating that
they suffer from Peripheral Neuropathy, there will be an
exponential growth in the number of patients in these regions with
Peripheral Neuropathy," mentioned Dr Ashley Barlow, Senior Director, Medical &
Technical Affairs, P&G Health – Asia
Pacific, India,
Middle East, and Africa.
"At P&G Health, we have always been committed to efforts
on increasing awareness around Peripheral Neuropathy and the
importance of nerve health. Neuropathy Awareness Week is a key
platform for the entire ecosystem to come together and discuss the
condition so that the community is more informed and able to take
mitigative steps. As a leader in nerve care, P&G Health is
committed to educating communities about the effects of Peripheral
Neuropathy on quality of life. We encourage everyone to don
the purple ribbon with us as we commemorate this important week for
better collective health," commented Aalok Agrawal, Senior Vice President, P&G
Health – Asia Pacific,
India, Middle East, and Africa.
P&G Health's 'Feel Life' campaign was inspired
by the symptoms felt by those with Peripheral Neuropathy, shedding
light on how those with the condition are not able to feel the same
joy and delight when going about routine activities, negatively
impacting their ability to get things done and consequentially
their emotional wellbeing.
Initiatives under the campaign include a social experience
activity led by prominent individuals on social media channels such
as Instagram wherein the public will be invited to partake in the
challenge by dunking their hands in a bowl of ice water for a short
period of time before trying to do one of their favourite daily
activities. By experiencing the effects of numbness and tingling,
the aim is to understand first-hand how the symptoms of Peripheral
Neuropathy can impact one's quality of life and encourage them to
seek timely treatment.
In addition to this, P&G Health is partnering with its
healthcare professionals' medical education network to organise a
'Global Webinar Series' with virtual pavilions representing
Peripheral neuropathy issues across countries with best practices,
patient case studies and expert panels. By bringing together
healthcare experts from across the globe and the region, the
webinars will cover the latest scientific updates on neuropathy
prevalence, treatment, and management.
Disclaimer: Indications of Neurobion may differ
in different countries, please check with your local healthcare
professionals for more information
About P&G Health:
P&G Health, the health care division of P&G company,
drives consumer-centric innovation to empower our consumers to live
longer, healthier, and more vibrant lives.
About Procter & Gamble:
P&G serves consumers around the world with one of the
strongest portfolios of trusted, quality, leadership brands,
including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®,
Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head &
Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®,
Tide®, Vicks®, and Whisper®. The P&G community includes
operations in approximately 70 countries worldwide.
[1] Landmann G.
Ars Medici. 2013;1: 18-21
|
[2] IDF Diabetes
Atlas. 10th edition, 2021
|
Photo
- https://mma.prnewswire.com/media/1817521/P_G_Health.jpg